title: Synchronous activation of ERK and phosphatidylinositol 3-kinase pathways is required for collagen and extracellular matrix production in keloids.
abstract: Keloid fibroproliferation appears to be influenced by epithelial-mesenchymal interactions between keloid keratinocytes (KKs) and keloid fibroblasts (KFs). Keloid and normal fibroblasts exhibit accelerated proliferation and collagen I and III production in co-culture with KKs compared with single cell culture or co-culture with normal keratinocytes. ERK and phosphatidylinositol 3-kinase (PI3K) pathway activation has been observed in excessively proliferating KFs in co-culture with KKs. We hypothesized that ERK and PI3K pathways might be involved in collagen and extracellular matrix production in KFs. To test our hypothesis, four samples of KFs were co-cultured in defined serum-free medium with KKs for 2-5 days. KF cell lysate was subjected to Western blot analysis. Compared with KF single cell culture, phospho-ERK1/2 and downstream phospho-Elk-1 showed up-regulation in the co-culture groups, as did phospho-PI3K and phospho-Akt-1, indicating ERK and PI3K pathway activation. Western blotting of the conditioned medium demonstrated increased collagen I-III, laminin beta2, and fibronectin levels. Addition of the MEK1/2-specific inhibitor U0126 or the PI3K-specific inhibitor LY294002 (but not p38 kinase and JNK inhibitors) completely nullified collagen I-III production and significantly decreased laminin beta2 and fibronectin secretion. In the presence of the MEK1/2 or PI3K inhibitor, fibronectin demonstrated changes in molecular mass reflected by faster in-gel migration. These data strongly suggest that synchronous activation of both the ERK and PI3K pathways is essential for collagen I-III and laminin beta2 production. These pathways additionally appear to affect the side chain attachments of fibronectin. Modulation of these pathways may suggest a direction for keloid therapy.
authors.affiliation: Departments of Surgery and Orthopaedic Surgery, National University of Singapore, 5, Lower Kent Ridge Road, Singapore 119074.
authors.forename: Ivor J
authors.initials: IJ
authors.lastname: Lim
authors.forename: Toan-Thang
authors.initials: TT
authors.lastname: Phan
authors.forename: Ee-Kim
authors.initials: EK
authors.lastname: Tan
authors.forename: Thi-Thanh T
authors.initials: TT
authors.lastname: Nguyen
authors.forename: Evelyne
authors.initials: E
authors.lastname: Tran
authors.forename: Michael T
authors.initials: MT
authors.lastname: Longaker
authors.forename: Colin
authors.initials: C
authors.lastname: Song
authors.forename: Seng-Teik
authors.initials: ST
authors.lastname: Lee
authors.forename: Hung-The
authors.initials: HT
authors.lastname: Huynh
mesh_terms: D015153:Blotting, Western; D002070:Butadienes / Q000494:pharmacology; D002455:Cell Division; D002867:Chromones / Q000494:pharmacology; D018920:Coculture Techniques; D003094:Collagen / Q000378:metabolism*; D017077:Culture Media, Conditioned / Q000494:pharmacology; D016895:Culture Media, Serum-Free / Q000494:pharmacology; D004789:Enzyme Activation; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005347:Fibroblasts / Q000378:metabolism; D005353:Fibronectins / Q000378:metabolism; D006801:Humans; D007627:Keloid / Q000378:metabolism*; D015603:Keratinocytes / Q000378:metabolism; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism*; D009025:Morpholines / Q000494:pharmacology; D009570:Nitriles / Q000494:pharmacology; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism*; D010766:Phosphorylation; D013997:Time Factors
chemical_list: D002070:Butadienes; D002867:Chromones; D017077:Culture Media, Conditioned; D016895:Culture Media, Serum-Free; D004791:Enzyme Inhibitors; D005353:Fibronectins; D009025:Morpholines; D009570:Nitriles; C113580:U 0126; C085911:2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one; D003094:Collagen; D019869:Phosphatidylinositol 3-Kinases; D020928:Mitogen-Activated Protein Kinases